Bactrim Dosing for Acute Urinary Tract Infection in Adult Females

First-Line Treatment Options

The Infectious Diseases Society of America (IDSA) recommends trimethoprim-sulfamethoxazole (160/800 mg) twice daily for 3 days as a first-line treatment for acute uncomplicated urinary tract infection in adult females, if local resistance rates do not exceed 20% 1
A 3-day regimen of trimethoprim-sulfamethoxazole is preferred over longer courses due to similar efficacy with fewer side effects, with clinical cure rates ranging from 90-100% in clinical trials 3, 4

The IDSA recommends a 3-day course of trimethoprim-sulfamethoxazole for uncomplicated cystitis in women, with a threshold of 20% resistance prevalence for empirical treatment 1, 2

Nitrofurantoin monohydrate/macrocrystals (100 mg twice daily for 5 days) and fosfomycin trometamol (3 g single dose) are alternative regimens for acute uncomplicated urinary tract infection in adult females 1, 5
Pivmecillinam (400 mg three times daily for 3-5 days) is also an alternative regimen, where available 1, 5

Studies show that 3-day regimens of trimethoprim-sulfamethoxazole have comparable efficacy to longer courses, but with fewer adverse effects, ranging from 1.4-31% compared to 15-38% for 10-day regimens 3, 4
Early clinical cure rates with the 3-day regimen range from 86-100%, and bacterial cure rates range from 85-100% 3, 4

Amoxicillin or ampicillin should not be used for empirical treatment due to poor efficacy and high prevalence of antimicrobial resistance, according to the IDSA 1, 3
If local resistance to trimethoprim-sulfamethoxazole exceeds 20%, alternative first-line agents should be considered, as recommended by the IDSA 1